Search results
Results from the WOW.Com Content Network
Trone is the co-chair of the Commission on Combating Synthetic Opioid Trafficking, a government commission created to develop solutions to the opioid epidemic. [152] In February 2022, Trone blamed China for causing 64,000 fentanyl deaths in the United States in 2021 "because they are pretty much the lone supplier of [fentanyl] precursor ...
A new report from the Commission on Combating Synthetic Opioid Trafficking, a bipartisan working group led by Rep. David Trone (D-MD) and Sen. Tom Cotton (R-AK), argued that the U.S. should shift ...
BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...
McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...
The university also began an "Opioid Stewardship Committee" to "…consistently and frequently address opioid stewardship." [3] Opioid data for Alabama indicated that, from 2006 to 2014 2.3 billion pain pills were prescribed in the state. McKesson Corporation distributed 728 million of these pain pills; Par Pharmaceutical manufactured 713 million.
The Modernizing Opioid Treatment Access Act is a proposed United States congressional bill introduced in the 118th United States Congress. Introduced in response to the national opioid epidemic , the legislation would expand access to methadone , an approved medication for treating opioid use disorder (OUD).
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...
SUPPORT for Patients and Communities Act, also known as Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, (H.R. 6, Pub. L. 115–271 (text)) is a United States federal law, enacted during the 115th United States Congress, to make medical treatment for opioid addiction more widely available while also cracking down on illicit drugs.